NanoViricides is trading at $1.52 (-5.28%) as the stock faces downward pressure in the absence of company-specific catalysts.
- The decline appears consistent with broader risk-off pressure across the biotechnology sector, with the XBI down 2.16% during the regular session.
- Market sentiment is currently weighed down by renewed geopolitical tensions and higher oil prices, contributing to a broader sell-off in speculative assets.